227 related articles for article (PubMed ID: 15989411)
1. Supplementation with DHEA: effect on muscle size, strength, quality of life, and lipids.
Dayal M; Sammel MD; Zhao J; Hummel AC; Vandenbourne K; Barnhart KT
J Womens Health (Larchmt); 2005 Jun; 14(5):391-400. PubMed ID: 15989411
[TBL] [Abstract][Full Text] [Related]
2. The effect of six months treatment with a 100 mg daily dose of dehydroepiandrosterone (DHEA) on circulating sex steroids, body composition and muscle strength in age-advanced men and women.
Morales AJ; Haubrich RH; Hwang JY; Asakura H; Yen SS
Clin Endocrinol (Oxf); 1998 Oct; 49(4):421-32. PubMed ID: 9876338
[TBL] [Abstract][Full Text] [Related]
3. DHEA in elderly women and DHEA or testosterone in elderly men.
Nair KS; Rizza RA; O'Brien P; Dhatariya K; Short KR; Nehra A; Vittone JL; Klee GG; Basu A; Basu R; Cobelli C; Toffolo G; Dalla Man C; Tindall DJ; Melton LJ; Smith GE; Khosla S; Jensen MD
N Engl J Med; 2006 Oct; 355(16):1647-59. PubMed ID: 17050889
[TBL] [Abstract][Full Text] [Related]
4. Relations between body composition, functional and hormonal parameters and quality of life in healthy postmenopausal women.
Lebrun CE; van der Schouw YT; de Jong FH; Pols HA; Grobbee DE; Lamberts SW
Maturitas; 2006 Aug; 55(1):82-92. PubMed ID: 16497451
[TBL] [Abstract][Full Text] [Related]
5. Short-term dehydroepiandrosterone treatment increases platelet cGMP production in elderly male subjects.
Martina V; Benso A; Gigliardi VR; Masha A; Origlia C; Granata R; Ghigo E
Clin Endocrinol (Oxf); 2006 Mar; 64(3):260-4. PubMed ID: 16487434
[TBL] [Abstract][Full Text] [Related]
6. Dehydroepiandrosterone replacement therapy in hypoadrenal women: protein anabolism and skeletal muscle function.
Dhatariya KK; Greenlund LJ; Bigelow ML; Thapa P; Oberg AL; Ford GC; Schimke JM; Nair KS
Mayo Clin Proc; 2008 Nov; 83(11):1218-25. PubMed ID: 18990320
[TBL] [Abstract][Full Text] [Related]
7. Endocrine effects of oral dehydroepiandrosterone in men with HIV infection: a prospective, randomized, double-blind, placebo-controlled trial.
Poretsky L; Brillon DJ; Ferrando S; Chiu J; McElhiney M; Ferenczi A; Sison MC; Haller I; Rabkin J
Metabolism; 2006 Jul; 55(7):858-70. PubMed ID: 16784956
[TBL] [Abstract][Full Text] [Related]
8. Effects of estrogen, raloxifene, and hormone replacement therapy on serum C-reactive protein and homocysteine levels.
Gol M; Akan P; Dogan E; Karas C; Saygili U; Posaci C
Maturitas; 2006 Feb; 53(3):252-9. PubMed ID: 15990257
[TBL] [Abstract][Full Text] [Related]
9. The Dehydroepiandrosterone And WellNess (DAWN) study: research design and methods.
von Mühlen D; Laughlin GA; Kritz-Silverstein D; Barrett-Connor E
Contemp Clin Trials; 2007 Feb; 28(2):153-68. PubMed ID: 16784898
[TBL] [Abstract][Full Text] [Related]
10. Dehydroepiandrosterone combined with exercise improves muscle strength and physical function in frail older women.
Kenny AM; Boxer RS; Kleppinger A; Brindisi J; Feinn R; Burleson JA
J Am Geriatr Soc; 2010 Sep; 58(9):1707-14. PubMed ID: 20863330
[TBL] [Abstract][Full Text] [Related]
11. Tibolone, transdermal estradiol or oral estrogen-progestin therapies: effects on circulating allopregnanolone, cortisol and dehydroepiandrosterone levels.
Pluchino N; Genazzani AD; Bernardi F; Casarosa E; Pieri M; Palumbo M; Picciarelli G; Gabbanini M; Luisi M; Genazzani AR
Gynecol Endocrinol; 2005 Mar; 20(3):144-9. PubMed ID: 16019353
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of dehydroepiandrosterone and its metabolites after long-term daily oral administration to healthy young men.
Acacio BD; Stanczyk FZ; Mullin P; Saadat P; Jafarian N; Sokol RZ
Fertil Steril; 2004 Mar; 81(3):595-604. PubMed ID: 15037408
[TBL] [Abstract][Full Text] [Related]
13. Serum steroid levels during 12-week intravaginal dehydroepiandrosterone administration.
Labrie F; Archer D; Bouchard C; Fortier M; Cusan L; Gomez JL; Girard G; Baron M; Ayotte N; Moreau M; Dubé R; Côté I; Labrie C; Lavoie L; Bérubé R; Bélanger P; Berger L; Gilbert L; Martel C; Balser J
Menopause; 2009; 16(5):897-906. PubMed ID: 19436226
[TBL] [Abstract][Full Text] [Related]
14. Androgens and sexual function: a placebo-controlled, randomized, double-blind study of testosterone vs. dehydroepiandrosterone in men with sexual dysfunction and androgen deficiency.
Morales A; Black A; Emerson L; Barkin J; Kuzmarov I; Day A
Aging Male; 2009 Dec; 12(4):104-12. PubMed ID: 19883295
[TBL] [Abstract][Full Text] [Related]
15. The effect of hormone replacement therapy on the levels of serum lipids, apolipoprotein AI, apolipoprotein B and lipoprotein (a) in Turkish postmenopausal women.
Bayrak A; Aldemir DA; Bayrak T; Corakçi A; Dursun P
Arch Gynecol Obstet; 2006 Aug; 274(5):289-96. PubMed ID: 16810536
[TBL] [Abstract][Full Text] [Related]
16. Long-term low-dose oral administration of dehydroepiandrosterone modulates adrenal response to adrenocorticotropic hormone in early and late postmenopausal women.
Genazzani AR; Pluchino N; Begliuomini S; Stomati M; Bernardi F; Pieri M; Casarosa E; Palumbo M; Genazzani AD; Luisi M
Gynecol Endocrinol; 2006 Nov; 22(11):627-35. PubMed ID: 17145649
[TBL] [Abstract][Full Text] [Related]
17. Effect of vitamin E supplementation with and without hormone therapy on circulatory inflammatory markers in postmenopausal women.
Carr BR; Khan N; Adams-Huet B; Kakarla N; Havelock JC; Gell J
Fertil Steril; 2006 Mar; 85(3):667-73. PubMed ID: 16500336
[TBL] [Abstract][Full Text] [Related]
18. Improvement of sustained attention and visual and movement skills, but not clinical symptoms, after dehydroepiandrosterone augmentation in schizophrenia: a randomized, double-blind, placebo-controlled, crossover trial.
Ritsner MS; Gibel A; Ratner Y; Tsinovoy G; Strous RD
J Clin Psychopharmacol; 2006 Oct; 26(5):495-9. PubMed ID: 16974191
[TBL] [Abstract][Full Text] [Related]
19. Dehydroepiandrosterone replacement in healthy men with age-related decline of DHEA-S: effects on fat distribution, insulin sensitivity and lipid metabolism.
Jedrzejuk D; Medras M; Milewicz A; Demissie M
Aging Male; 2003 Sep; 6(3):151-6. PubMed ID: 14628495
[TBL] [Abstract][Full Text] [Related]
20. Quality of life assessment in a chemoprevention trial: fenretinide and oral or transdermal HRT.
Serrano D; Mariani L; Mora S; Guerrieri-Gonzaga A; Cazzaniga M; Daldoss C; Ramazzotto F; Feroce I; Decensi A; Bonanni B
Maturitas; 2006 Aug; 55(1):69-75. PubMed ID: 16500052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
